Skip to main content
About us
Overview
Senior Management
Board of Directors
Investors
Platform
Background
Hybrid interferons
Our pipeline
Alfacyte™
News and events
Press releases
Newsroom
Contact
Investors
To find out more about investment opportunities with us,
please get in touch
.